BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 18165191)

  • 1. Design and evaluation of sustained release bilayer tablets of propranolol hydrochloride.
    Patra CN; Kumar AB; Pandit HK; Singh SP; Devi MV
    Acta Pharm; 2007 Dec; 57(4):479-89. PubMed ID: 18165191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of propranolol hydrochloride release from matrix tablets with KollidonSR or hydroxy propyl methyl cellulose.
    Sahoo J; Murthy PN; Biswal S; Sahoo SK; Mahapatra AK
    AAPS PharmSciTech; 2008; 9(2):577-82. PubMed ID: 18459050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of xanthan gum based sustained release matrix tablets containing highly water-soluble propranolol HCl.
    Ali A; Iqbal M; Akhtar N; Khan HM; Ullah A; Uddin M; Khan MT
    Acta Pol Pharm; 2013; 70(2):283-9. PubMed ID: 23614284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hydrophilic natural gums in formulation of oral-controlled release matrix tablets of propranolol hydrochloride.
    Rajesh KS; Venkataraju MP; Gowda DV
    Pak J Pharm Sci; 2009 Apr; 22(2):211-9. PubMed ID: 19339235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation of sustained-release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit RLPO or Kollidon SR.
    Sahoo J; Murthy PN; Biswal S; Manik
    AAPS PharmSciTech; 2009; 10(1):27-33. PubMed ID: 19145487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices.
    Javadzadeh Y; Musaalrezaei L; Nokhodchi A
    Int J Pharm; 2008 Oct; 362(1-2):102-8. PubMed ID: 18647643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride.
    Baviskar D; Sharma R; Jain D
    Pak J Pharm Sci; 2013 Jan; 26(1):137-44. PubMed ID: 23261739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilayer Tablet Formulation of Metformin HCl and Acarbose: A Novel Approach To Control Diabetes.
    Tiwari R; Gupta A; Joshi M; Tiwari G
    PDA J Pharm Sci Technol; 2014; 68(2):138-52. PubMed ID: 24668601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release behaviour of propranolol HCl from hydrophilic matrix tablets containing psyllium powder in combination with hydrophilic polymers.
    Siahi-Shadbad MR; Asare-Addo K; Azizian K; Hassanzadeh D; Nokhodchi A
    AAPS PharmSciTech; 2011 Dec; 12(4):1176-82. PubMed ID: 21918920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of a gastroretentive drug delivery system for the low-absorption-window drug celecoxib.
    Ali J; Tyagi P; Ahuja A; Baboota S; Hasan S
    PDA J Pharm Sci Technol; 2007; 61(2):88-96. PubMed ID: 17479716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM; Sankalia MG; Mashru RC
    J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug release from hydroethanolic gels. Effect of drug's lipophilicity (logP), polymer-drug interactions and solvent lipophilicity.
    Sawant PD; Luu D; Ye R; Buchta R
    Int J Pharm; 2010 Aug; 396(1-2):45-52. PubMed ID: 20540996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissolution kinetics evaluation of controlled-release tablets containing propranolol hydrochloride.
    Velasco-De-Paola MV; Santoro MI; Gai MN
    Drug Dev Ind Pharm; 1999 Apr; 25(4):535-41. PubMed ID: 10194610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and in-vitro evaluation of floating bilayer tablet of lisinopril maleate and metoprolol tartrate.
    Ijaz H; Qureshi J; Danish Z; Zaman M; Abdel-Daim M; Hanif M; Waheed I; Mohammad IS
    Pak J Pharm Sci; 2015 Nov; 28(6):2019-25. PubMed ID: 26639495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the molecular size of carboxymethylcellulose and some polymers on the sustained release of theophylline from a hydrophilic matrix.
    Emeje MO; Kunle OO; Ofoefule SI
    Acta Pharm; 2006 Sep; 56(3):325-35. PubMed ID: 19831281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of floating bilayer tablets of diltiazem hydrochloride and lovastatin.
    Kulkarni AS; Bhatia MS
    PDA J Pharm Sci Technol; 2008; 62(5):344-52. PubMed ID: 19055230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating tamsulosin hydrochloride-released microparticles prepared using single-step matrix coating.
    Maeda A; Shinoda T; Ito N; Baba K; Oku N; Mizumoto T
    Int J Pharm; 2011 Apr; 408(1-2):84-90. PubMed ID: 21291970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of release of hydroxypropylmethyl cellulose on single and bilayer sustained-release matrix tablets].
    Yang YP; Wang MY; Chang JB; Guo MT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):291-6. PubMed ID: 23591354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.